Literature DB >> 19382803

Dendrimers bind human serum albumin.

E Froehlich1, J S Mandeville, C J Jennings, R Sedaghat-Herati, H A Tajmir-Riahi.   

Abstract

Dendrimers are synthetic, highly branched, spherical macromolecules with nanometer dimensions and potential applications in DNA and drug delivery systems. Human serum albumin (HSA) is a major transporter for delivering several endogenous compounds and drugs in vivo. The aim of this study was to examine the interaction of human serum albumin with several dendrimers such as mPEG-PAMAM (G3), mPEG-PAMAM (G4), and PAMAM (G4) at physiological conditions, using constant protein concentration and various dendrimer compositions. FTIR, UV-visible, CD, and fluorescence spectroscopic methods were used to analyze macromolecule binding mode, the binding constant and the effects of dendrimers complexation on HSA stability and conformation. Structural analysis showed that dendrimers bind HSA via polypeptide polar groups (hydrophilic) with number of bound polymer (n) 1.08 (mPEG-PAMAM-G3), 1.50 (mPEG-PAMAM-G4), and 0.96 (PAMAM-G4). The overall binding constants estimated were of KmPEG-G3=1.3 (+/-0.2)x10(4) M(-1), KmPEG-G4=2.2 (+/-0.4)x10(4) M(-1), and KPAMAM-G4=2.6 (+/-0.5)x10(4) M(-1). HSA conformation was altered by dendrimers with a major reduction of alpha-helix and increase in random coil and turn structures suggesting a partial protein unfolding.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19382803     DOI: 10.1021/jp9011119

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  30 in total

1.  Interaction of human serum albumin with 10-hydroxycamptothecin: spectroscopic and molecular modeling studies.

Authors:  Hui-Hui Sun; Jing Zhang; Ye-Zhong Zhang; Li-Yun Yang; Li-Li Yuan; Yi Liu
Journal:  Mol Biol Rep       Date:  2011-12-09       Impact factor: 2.316

2.  Molecular dynamics simulation studies of betulinic acid with human serum albumin.

Authors:  Chandramouli Malleda; Navjeet Ahalawat; Mahesh Gokara; Rajagopal Subramanyam
Journal:  J Mol Model       Date:  2011-11-11       Impact factor: 1.810

3.  Determination of the specific interaction between palmatine and bovine serum albumin.

Authors:  Yu Ou-Yang; Xiao-Ling Li; Hong Wang; Min Fang; Yan-Jun Hu
Journal:  Mol Biol Rep       Date:  2011-12-21       Impact factor: 2.316

4.  Spectroscopic Study of the Interactions of Ruthenium-Ketoconazole Complexes of Known Antiparasitic Activity with Human Serum Albumin and Apotransferrin.

Authors:  Jesús G Estrada; Roberto A Sánchez-Delgado
Journal:  J Mex Chem Soc       Date:  2013       Impact factor: 0.524

5.  Biogenic and synthetic polyamines bind bovine serum albumin.

Authors:  S Dubeau; P Bourassa; T J Thomas; H A Tajmir-Riahi
Journal:  Biomacromolecules       Date:  2010-06-14       Impact factor: 6.988

6.  Physicochemical and Antioxidant Properties of Riboflavin in Dextran70/HSA Systems.

Authors:  Mariana Voicescu; Sorana Ionescu; Cecilia Lete
Journal:  J Fluoresc       Date:  2018-06-26       Impact factor: 2.217

7.  Encapsulation of micronutrients resveratrol, genistein, and curcumin by folic acid-PAMAM nanoparticles.

Authors:  P Chanphai; H A Tajmir-Riahi
Journal:  Mol Cell Biochem       Date:  2018-05-21       Impact factor: 3.396

8.  Effect of a Synthesized Amyl-Glycine1, 10-Phenanthroline Platinum Nitrate on Structure and Stability of Human Blood Carrier Protein, Albumin: Spectroscopic and Modeling Approaches.

Authors:  Zahra Shafaei; Omid Abazari; Adeleh Divsalar; Behafarid Ghalandari; Atefeh Poursoleiman; Ali Akbar Saboury; Faizan Ahmad
Journal:  J Fluoresc       Date:  2017-05-29       Impact factor: 2.217

9.  Computational studies of the binding mechanisms of fullerenes to human serum albumin.

Authors:  Jinyu Li; Lizhi Jiang; Xiaolei Zhu
Journal:  J Mol Model       Date:  2015-06-21       Impact factor: 1.810

10.  Molecular interaction studies of trimethoxy flavone with human serum albumin.

Authors:  Mahesh Gokara; Babu Sudhamalla; Damu G Amooru; Rajagopal Subramanyam
Journal:  PLoS One       Date:  2010-01-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.